'Your science is only as good as your implementation science' #cmgsays again ...

Dr. Jim Januzzi ( James Januzzi Jr MD ) and I talk about implementation science in general but some of the advances he and his team are making in the heart failure space in particular which were presented

Dr. Laura Cohen presenting the #TEAMHF echo data after rapid #GDMTworks clinic titration

Average 6% LVEF rise
>60% with 🔼LVEF from below to above 35%
50% 🔽in 3-4+ MR

These results emphasize the value of GDMT programs!

Mass General Heart HFAPresident

Thank you Ahmed Bennis for this post.

So proud of Laura Cohen for this important work—the consequences of implementing #GDMTworks : reverse cardiac remodeling in the TEAM HF study.

Excellent #LBCT presentation by Laura Cohen on cardiac reverse remodeling following an accelerated GDMT uptitration program #TEAMHF !

🔑 findings 👇

#HeartFailure2024

With Dr Laure Cohen ( TEAM-HF) and Dr Manel EL BLIDI James Januzzi Jr MD

#HeartFailure2024

Cardiac reverse remodeling in the trial of accelerated guideline-directed medical therapy for Heart Failure (TEAM-HF)
Amazing

#HeartFailure2024
Together we are STRONGer. Efficacy of a multidisciplinary approach for fast up titration in patients with #HF . The TEAM-HF.

#HF A_ESC Aferdita Spahillari

Even so, it's important to at least try SGLT2 inhibitors in HFpEF patients who are good candidates, Laura Cohen says. 'These are the only drugs that have shown a proven benefit in RCTs in improving CV outcomes' in this population TCTMD Dhruv Kazi tctmd.com/news/borderlin…

Leonard Chiu, MD MS Katie Truong, MD Neal Dixit, MD Muthu Vaduganathan Boback Ziaeian 🤦🏻‍♂️ American College of Cardiology Laura Cohen Dhruv Kazi Provides a cost-effectiveness/value perspective to these 💊💊💊 individually and in combination in HFpEF

Class 2 (a/b) recommendations in HF guidelines

SGLT2i+MRA+ARNI combo ➡️ intermediate value

Results of economic evaluation suggest that at 2022 drug prices, adding an SGLT2-I to standard of care was of intermediate or low economic value compared with standard of care in US adults with HFpEF. ja.ma/41KDMWI #ACC23 #WCCardio Inmaculada (Inma) Hernández

Healthy habits and nutritional interventions are at the ♥️ of the matter. Shedding light where it's due in HF. Congrats to Columbia Cardiology Elissa Driggin, MD MS Laura Cohen mathew.maurer and colleagues on their JACC review jacc.org/doi/pdf/10.101…

Check out our review on nutrition assessment and dietary interventions in heart failure this week in JACC Journals 🍏🧂❤️mathew.maurer Salvatore Carbone, PhD, FHFSA, FASPEN Scott Hummel Laura Cohen Thomas M. Maddox MD jacc.org/doi/full/10.10…

President Biden signed the Dr. Lorna Breen Health Care Provider Protection Act, which aims to reduce and prevent suicide, burnout, and behavioral health conditions among health care professionals.

Fundamentally:

—Vaccinate/BOOST
—Mask (consider N95s esp to protect elderly/immunocompromised)
—Balance risk/benefit: Do what’s most important to you, as safely as possible
—Protect health care/health workers

Never forget, so we never go through anything like this again. 21/end

Congrats to graduating Columbia Cardiology Fellows fellows Laura Cohen, @ersied727 and Shawn Gogia for presenting their graduating talks on heart failure subtypes, sex-specific outcomes in heart failure, and intravascular imaging and physiology in the cath lab. Outstanding presentations!

Congratulations Lama Ghazi, MD PhD & coauthors Laura Cohen
Paul Muntner Daichi Shimbo MD Paul Drawz 👏👏

Great to see these SPRINT ABPM data!
Will need to review paper but surprised to see fr those with controlled office BP have high prevalence of #MUCH 62% & 56% in intensive vs std group

💕ed writing the editorial for this study in Hypertension by Laura Cohen Natalie Bello MD MPH Daichi Shimbo MD! In pts not on BP meds, 24-26% had masked HTN, w/81% agreement across 2 ABPMs. Need more self monitoring 🏠 BP!

Paper 👉 ahajournals.org/doi/10.1161/HY…

Editorial 👉 ahajournals.org/doi/10.1161/HY…